TOR1A, THAP1, and GNAL mutational screening in Austrian patients with primary isolated dystonia.
Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.|Institut für Neurogenomik, Helmholtz Zentrum München, Munich, Germany.
Michael
M
Zech
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Sylvia
S
Boesch
Department of Neurology, Medical University Vienna, Vienna, Austria.
Thomas
T
Sycha
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.|Vivantes Klinikum Spandau, Berlin, Germany.
Joerg
J
Mueller
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Werner
W
Poewe
Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.|Institut für Neurogenomik, Helmholtz Zentrum München, Munich, Germany.|Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.
Juliane
J
Winkelmann
D051017:Apoptosis Regulatory Proteins / Q000235:genetics*; D001317:Austria; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D020821:Dystonic Disorders / Q000235:genetics*; D005260:Female; D044385:GTP-Binding Protein alpha Subunits / Q000235:genetics*; D006801:Humans; D008297:Male; D018832:Molecular Chaperones / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*
D051017:Apoptosis Regulatory Proteins; D004268:DNA-Binding Proteins; D044385:GTP-Binding Protein alpha Subunits; D018832:Molecular Chaperones; D009687:Nuclear Proteins; C474080:THAP1 protein, human; C108175:TOR1A protein, human; C084618:olfactory G protein subunit alpha olf